Clinical trial · Interventional
M-POWER Feasibility Study
Mobile - PrOmoting Wellness After cancER Study: M-POWER Feasibility Study
NCT05921565CI-TRIAL-00071213M-POWERcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to test a new weight loss intervention designed for cancer survivors who have heart disease or cardiometabolic conditions. The investigators want to determine whether this study is feasible and acceptable to participants. The investigators also want to learn more about how cancer survivors take their medications.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adherence, Patient | — | UNRESOLVED | — |
| Weight Reduction | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Interventional Behavioral Arm | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Single Behavioral Arm
- description
- Everyone in the study will receive the same type of treatment. They will all receive a treatment period that will last for 8 weeks. All participants will be given a 3% total weight loss goal, a daily calorie goal ranging from 1200-2000 kcal/day based on body weight, and a daily fat goal based on 25% of total daily calories from fat, and an option to stop their food/energy intake at 6pm every day without altering any other meal times. .Participants will also be asked to use two meal replacements per day. Participants will also be given a physical activity goal of 100 minutes per week.
- interventionNames
- Behavioral: Interventional Behavioral Arm
Primary outcomes (1)
- measure
- Primary Outcome - Weight - Aria Scale
- timeFrame
- Baseline (week one) & Follow Up (week 8)
- description
- Weight will be measured in the lab at baseline and then the change in weight at the follow-up. Baseline measurements occur one week before the study and follow up measurements occur at week 8 of the study. Measurements will be taken without shoes, wearing light clothing on a calibrated beam balance scale called the Aria Scale. For melanoma patients only, skin self-examination frequency will also be assessed.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 84 Years
Show eligibility criteria text
Inclusion Criteria: * Cancer survivors between ages 18 and 84 * BMI between ≥25 - 45 kg/m2 * \<350 lbs.; weight stable (no loss or gain \>15 lbs. for the past 3 months) * Own a smartphone (Android or iOS) and web camera, be willing to install the M-POWER App * Will voluntarily provide informed consent * Reside in the Chicagoland area for the duration of their participation (i.e., 3 months) * Maintain at-home internet and WiFi service for the entirety of their participation * Cancer survivors with a history of breast cancer (up to stage IIIa), melanoma (up to stage IIb), prostate cancer (up to stage IIIb) or colorectal cancer (up to stage IIIa). Exclusion Criteria: * Inability to speak and read English * Unstable medical conditions * Uncontrolled hypertension * Diabetes - uncontrolled or treated with insulin * Uncontrolled hypothyroidism * Unstable angina pectoris * Transient ischemic attack * Cancer undergoing active treatment (\< 3 months since most recent surgery, chemotherapy, or radiation treatment for cancer) * Cerebrovascular accident or myocardial infarction within the past six months, Crohn's disease) * Pregnancy, lactation or intended pregnancy * Active suicidal ideation * Anorexia * Bulimia * Binge eating disorder * Requiring an assistive device for mobility, or those with any current condition that may limit or prevent participation in moderate physical activity * Upcoming reconstructive surgery scheduled to take place during the study period and/or \< 3months have elapsed since reconstructive surgery * Substance abuse or dependence besides nicotine dependence * Active treatment of the primary cancer * Individuals that have ever had bariatric (or LapBand surgery)
References
Publications (0)
Data not yet available
No reference posted for this study.